Skip to main content

Palo Alto Investors LP

13F filer · CIK 0001306923
Reported Aug 19, 2026
Net seller this quarter
13F portfolio value$724MU.S. long equity reported on 13F
Positions523 new · 2 closed
Net flow last quarter-$28.4MBuys minus sells
Top 10 positions weight61.3%Concentration

Holdings

13F · last 4 quarters free
Scroll for earlier quarters
CompanyValue% of portfolio% of companyPOSITION CHANGE qoq %First reported
Q2 2026Reported Aug 19, 202652 positions
PTCTPTC Therapeutics, Inc.$75M10.36%1.10%-0.3%Q3 2024
ACADAcadia Pharmaceuticals Inc$72.5M10.01%1.66%-0.3%Q1 2016
INSMINSMED Inc$44.1M6.10%0.19%-0.3%Q2 2013
MIRMMirum Pharmaceuticals, Inc.$40.8M5.64%0.54%+7.3%Q4 2021
ANABAnaptysbio, Inc$40.7M5.63%2.07%-37.0%Q3 2020
BMRNBiomarin Pharmaceutical Inc$39.1M5.40%0.35%-0.4%Q2 2013
DYNDyne Therapeutics, Inc.$36.6M5.06%0.99%-0.3%Q1 2025
UTHRUNITED THERAPEUTICS Corp$33.9M4.69%0.15%-0.4%Q2 2013
IRONDisc Medicine, Inc.$30.5M4.21%1.09%+3.7%Q2 2025
BIIBBiogen Inc.$30.3M4.19%0.10%-0.3%Q4 2020
IOVAIovance Biotherapeutics, Inc.$22M3.04%1.17%-16.6%Q4 2023
RAREUltragenyx Pharmaceutical Inc.$19.9M2.75%0.61%Not reportedQ2 2025
NVCRNovoCure Ltd$19.4M2.68%1.10%Not reportedQ1 2023
SNDXSyndax Pharmaceuticals Inc$18.9M2.61%0.97%Not reportedQ1 2020
ANNXAnnexon, Inc.$16.8M2.33%1.97%Not reportedQ4 2025
BCAXBicara Therapeutics Inc.$16.3M2.26%0.83%Not reportedQ4 2025
CDNACareDx, Inc.$15.2M2.09%1.03%Not reportedQ3 2025
CLDXCelldex Therapeutics, Inc.$14.9M2.06%0.51%+34.9%Q1 2026
CMPXCompass Therapeutics, Inc.$12.8M1.76%3.24%+285.1%Q4 2025
ALKSAlkermes plc.$12.7M1.76%0.14%Not reportedQ4 2020
TRAXFirst Tracks Biotherapeutics, Inc.$12.1M1.68%1.71%NewQ2 2026
PRTAProthena Corp Public Ltd Co$11.2M1.55%2.21%-5.4%Q2 2013
TVTXTravere Therapeutics, Inc.$9.52M1.32%0.18%-27.3%Q4 2020
TSHATaysha Gene Therapies, Inc.$9.48M1.31%0.43%Not reportedQ4 2023
ACRSAclaris Therapeutics, Inc.$8.54M1.18%1.15%Not reportedQ1 2024
AGIOAgios Pharmaceuticals, Inc.$7.93M1.10%0.36%Not reportedQ1 2025
CAPRCapricor Therapeutics, Inc.$5.53M0.76%0.40%Not reportedQ4 2025
ALGNAlign Technology Inc$5.29M0.73%0.04%-24.4%Q1 2014
ORKAOruka Therapeutics, Inc.$3.19M0.44%0.05%-44.1%Q3 2025
XENEXenon Pharmaceuticals Inc.$3.1M0.43%0.05%Not reportedQ4 2025
NBIXNeurocrine Biosciences Inc$3.05M0.42%0.02%Not reportedQ1 2025
EWEdwards Lifesciences Corp$3.04M0.42%0.01%Not reportedQ3 2024
STOKStoke Therapeutics, Inc.$2.77M0.38%0.14%Not reportedQ1 2024
CYTKCytokinetics Inc$2.74M0.38%0.03%Not reportedQ2 2013
PYXSPyxis Oncology, Inc.$2.6M0.36%1.36%-14.5%Q3 2024
EHTHeHealth, Inc.$2.21M0.31%4.67%Not reportedQ3 2020
CRSPCRISPR Therapeutics AG$2.16M0.30%0.04%Not reportedQ2 2025
SGMTSagimet Biosciences Inc.$1.93M0.27%0.82%NewQ2 2026
NUVBNuvation Bio Inc.$1.86M0.26%0.09%-35.8%Q1 2024
BNTXBioNTech SE$1.83M0.25%0.01%Not reportedQ3 2024
CMPSCOMPASS Pathways plc$1.64M0.23%0.09%Not reportedQ4 2025
HUMHumana Inc$1.58M0.22%0.00%Not reportedQ1 2024
NAMSNewAmsterdam Pharma Co N.V.$1.5M0.21%0.04%NewQ2 2026
VSTMVerastem, Inc.$1.18M0.16%0.34%+25.8%Q1 2026
MDGLMadrigal Pharmaceuticals, Inc.$960K0.13%0.01%Not reportedQ1 2026
URGNUroGen Pharma Ltd.$902K0.12%0.05%Not reportedQ1 2020
BCYCBicycle Therapeutics PLC$856K0.12%0.29%Not reportedQ3 2024
XERSXeris Biopharma Holdings, Inc.$827K0.11%0.06%Not reportedQ1 2026
ABEOAbeona Therapeutics Inc.$673K0.09%0.19%Not reportedQ3 2024
INSPInspire Medical Systems, Inc.$391K0.05%0.03%Not reportedQ4 2025
Q1 2026Reported May 15, 202651 positions
INSMINSMED Inc$67.9M10.39%0.19%-15.2%Q2 2013
ACADAcadia Pharmaceuticals Inc$63.9M9.78%1.68%+15.7%Q1 2016
PTCTPTC Therapeutics, Inc.$62.8M9.60%1.11%+2.0%Q3 2024
BMRNBiomarin Pharmaceutical Inc$38.7M5.92%0.35%-8.2%Q2 2013
UTHRUNITED THERAPEUTICS Corp$37.2M5.70%0.15%+8.0%Q2 2013
ANABAnaptysbio, Inc$35.4M5.41%2.20%-7.5%Q3 2020
MIRMMirum Pharmaceuticals, Inc.$30M4.59%0.53%+107.9%Q4 2021
DYNDyne Therapeutics, Inc.$30M4.58%1.00%+12.3%Q1 2025
BIIBBiogen Inc.$25.8M3.95%0.10%-23.3%Q4 2020
IRONDisc Medicine, Inc.$25.7M3.93%1.05%+26.5%Q2 2025
IOVAIovance Biotherapeutics, Inc.$22.3M3.41%1.45%-10.8%Q4 2023
SNDXSyndax Pharmaceuticals Inc$20.2M3.09%0.98%+8.9%Q1 2020
ANNXAnnexon, Inc.$16.3M2.50%1.97%+23.7%Q4 2025
FOLDAmicus Therapeutics, Inc.$16.1M2.46%0.35%-78.6%Q2 2013
NVCRNovoCure Ltd$14M2.13%1.11%-1.4%Q1 2023
RAREUltragenyx Pharmaceutical Inc.$12.5M1.91%0.61%+29.3%Q2 2025
PRTAProthena Corp Public Ltd Co$11.7M1.80%2.28%-8.5%Q2 2013
BCAXBicara Therapeutics Inc.$10.9M1.67%0.84%+84.3%Q4 2025
CLDXCelldex Therapeutics, Inc.$9.4M1.44%0.45%NewQ1 2026
CDNACareDx, Inc.$9.23M1.41%1.04%+11.2%Q3 2025
ALKSAlkermes plc.$8.58M1.31%0.15%Not reportedQ4 2020
CMPXCompass Therapeutics, Inc.$8.01M1.23%0.84%-40.2%Q4 2025
AGIOAgios Pharmaceuticals, Inc.$7.23M1.11%0.36%+0.5%Q1 2025
ALGNAlign Technology Inc$7.12M1.09%0.06%Not reportedQ1 2014
CAPRCapricor Therapeutics, Inc.$6.98M1.07%0.40%+1.5%Q4 2025
TVTXTravere Therapeutics, Inc.$6.85M1.05%0.25%+108.1%Q4 2020
TSHATaysha Gene Therapies, Inc.$6.22M0.95%0.48%+17.6%Q4 2023
ACRSAclaris Therapeutics, Inc.$6.05M0.93%1.16%+3.0%Q1 2024
DNLIDenali Therapeutics Inc.$4.5M0.69%0.15%-63.4%Q2 2025
XENEXenon Pharmaceuticals Inc.$2.99M0.46%0.05%-46.8%Q4 2025
ORKAOruka Therapeutics, Inc.$2.94M0.45%0.12%Not reportedQ3 2025
STOKStoke Therapeutics, Inc.$2.76M0.42%0.14%+17.5%Q1 2024
EWEdwards Lifesciences Corp$2.69M0.41%0.01%Not reportedQ3 2024
NBIXNeurocrine Biosciences Inc$2.39M0.37%0.02%Not reportedQ1 2025
NUVBNuvation Bio Inc.$2.18M0.33%0.15%-5.4%Q1 2024
CYTKCytokinetics Inc$2.12M0.32%0.03%Not reportedQ2 2013
EHTHeHealth, Inc.$1.91M0.29%4.77%-3.2%Q3 2020
CRSPCRISPR Therapeutics AG$1.88M0.29%0.04%-3.9%Q2 2025
BNTXBioNTech SE$1.74M0.27%0.01%Not reportedQ3 2024
PYXSPyxis Oncology, Inc.$1.48M0.23%1.61%-2.6%Q3 2024
VSTMVerastem, Inc.$1.3M0.20%0.28%NewQ1 2026
BCYCBicycle Therapeutics PLC$937K0.14%0.29%-8.7%Q3 2024
MDGLMadrigal Pharmaceuticals, Inc.$935K0.14%0.01%NewQ1 2026
HUMHumana Inc$691K0.11%0.00%Not reportedQ1 2024
CMPSCOMPASS Pathways plc$639K0.10%0.09%Not reportedQ4 2025
XERSXeris Biopharma Holdings, Inc.$606K0.09%0.06%NewQ1 2026
ABEOAbeona Therapeutics Inc.$488K0.07%0.19%Not reportedQ3 2024
INSPInspire Medical Systems, Inc.$452K0.07%0.03%Not reportedQ4 2025
URGNUroGen Pharma Ltd.$441K0.07%0.05%Not reportedQ1 2020
PRQRProQR Therapeutics N.V.$306K0.05%0.18%Not reportedQ3 2025
Q4 2025Reported Feb 17, 202649 positions
INSMINSMED Inc$85.2M11.86%0.23%-0.5%Q2 2013
FOLDAmicus Therapeutics, Inc.$74.1M10.32%1.67%-3.0%Q2 2013
PTCTPTC Therapeutics, Inc.$68.7M9.56%1.11%+4.8%Q3 2024
ACADAcadia Pharmaceuticals Inc$66.3M9.24%1.46%+0.7%Q1 2016
BMRNBiomarin Pharmaceutical Inc$44.3M6.17%0.39%-1.0%Q2 2013
ANABAnaptysbio, Inc$33.5M4.66%2.46%+2.5%Q3 2020
BIIBBiogen Inc.$32.3M4.50%0.13%-1.1%Q4 2020
DYNDyne Therapeutics, Inc.$28.8M4.01%0.89%+16.6%Q1 2025
UTHRUNITED THERAPEUTICS Corp$28.4M3.95%0.13%Not reportedQ2 2013
IRONDisc Medicine, Inc.$25.2M3.51%0.84%+41.5%Q2 2025
IOVAIovance Biotherapeutics, Inc.$19.4M2.70%1.73%-6.6%Q4 2023
NVCRNovoCure Ltd$16.8M2.34%1.15%+3.4%Q1 2023
SNDXSyndax Pharmaceuticals Inc$16.7M2.32%0.91%+21.3%Q1 2020
GOSSGossamer Bio, Inc.$13.9M1.93%1.91%-18.2%Q2 2020
CMPXCompass Therapeutics, Inc.$13.6M1.89%1.42%NewQ4 2025
PRTAProthena Corp Public Ltd Co$12.6M1.76%2.45%-0.3%Q2 2013
MIRMMirum Pharmaceuticals, Inc.$12.4M1.72%0.30%+141.8%Q4 2021
ANNXAnnexon, Inc.$12M1.67%1.60%NewQ4 2025
RAREUltragenyx Pharmaceutical Inc.$10.6M1.48%0.48%+24.8%Q2 2025
DNLIDenali Therapeutics Inc.$10.6M1.47%0.41%+57.2%Q2 2025
CDNACareDx, Inc.$9.01M1.25%0.94%+51.2%Q3 2025
EHTHeHealth, Inc.$7.04M0.98%4.94%-0.9%Q3 2020
ALKSAlkermes plc.$6.79M0.94%0.15%+31.9%Q4 2020
CAPRCapricor Therapeutics, Inc.$6.53M0.91%0.39%NewQ4 2025
TSHATaysha Gene Therapies, Inc.$6.51M0.91%0.42%-5.0%Q4 2023
ALGNAlign Technology Inc$6.48M0.90%0.06%-9.2%Q1 2014
AGIOAgios Pharmaceuticals, Inc.$5.78M0.81%0.36%-20.0%Q1 2025
BCAXBicara Therapeutics Inc.$5.03M0.70%0.53%NewQ4 2025
NUVBNuvation Bio Inc.$4.82M0.67%0.16%-47.3%Q1 2024
ACRSAclaris Therapeutics, Inc.$4.72M0.66%1.30%Not reportedQ1 2024
XENEXenon Pharmaceuticals Inc.$4.33M0.60%0.12%NewQ4 2025
TVTXTravere Therapeutics, Inc.$4.23M0.59%0.12%Not reportedQ4 2020
EWEdwards Lifesciences Corp$2.87M0.40%0.01%Not reportedQ3 2024
NBIXNeurocrine Biosciences Inc$2.57M0.36%0.02%Not reportedQ1 2025
STOKStoke Therapeutics, Inc.$2.29M0.32%0.12%-31.7%Q1 2024
CRSPCRISPR Therapeutics AG$2.16M0.30%0.04%Not reportedQ2 2025
BNTXBioNTech SE$1.87M0.26%0.01%Not reportedQ3 2024
ORKAOruka Therapeutics, Inc.$1.82M0.25%0.12%Not reportedQ3 2025
BCYCBicycle Therapeutics PLC$1.57M0.22%0.32%Not reportedQ3 2024
PYXSPyxis Oncology, Inc.$1.19M0.17%1.65%Not reportedQ3 2024
ALDXAldeyra Therapeutics, Inc.$1.17M0.16%0.37%Not reportedQ2 2019
HUMHumana Inc$1.02M0.14%0.00%Not reportedQ1 2024
INSPInspire Medical Systems, Inc.$809K0.11%0.03%NewQ4 2025
CMPSCOMPASS Pathways plc$798K0.11%0.12%NewQ4 2025
URGNUroGen Pharma Ltd.$574K0.08%0.05%Not reportedQ1 2020
ABEOAbeona Therapeutics Inc.$574K0.08%0.20%Not reportedQ3 2024
PRQRProQR Therapeutics N.V.$381K0.05%0.18%Not reportedQ3 2025
GBIOGeneration Bio Co.$85.5K0.01%0.22%Not reportedQ2 2024
AKTXAkari Therapeutics Plc$42.2K0.01%0.00%Not reportedQ4 2024
Q3 2025Reported Nov 14, 202544 positions
INSMINSMED Inc$70.8M13.11%0.23%-43.2%Q2 2013
PTCTPTC Therapeutics, Inc.$52.9M9.80%1.08%+112.2%Q3 2024
ACADAcadia Pharmaceuticals Inc$52.6M9.74%1.46%-3.8%Q1 2016
FOLDAmicus Therapeutics, Inc.$42.3M7.83%1.74%-4.3%Q2 2013
BMRNBiomarin Pharmaceutical Inc$40.8M7.56%0.39%-10.3%Q2 2013
BIIBBiogen Inc.$26M4.81%0.13%-9.8%Q4 2020
UTHRUNITED THERAPEUTICS Corp$24.4M4.51%0.14%-39.1%Q2 2013
ANABAnaptysbio, Inc$20.6M3.82%2.44%-17.1%Q3 2020
IOVAIovance Biotherapeutics, Inc.$16.5M3.06%1.98%+122.2%Q4 2023
NVCRNovoCure Ltd$16.2M3.00%1.12%+30.5%Q1 2023
DYNDyne Therapeutics, Inc.$16M2.96%0.89%+376.5%Q1 2025
IRONDisc Medicine, Inc.$14.8M2.74%0.64%+54.0%Q2 2025
ALNYAlnylam Pharmaceuticals, Inc.$14.7M2.73%0.02%-57.2%Q4 2023
GOSSGossamer Bio, Inc.$14.4M2.66%2.36%-4.8%Q2 2020
PRTAProthena Corp Public Ltd Co$12.9M2.39%2.46%+3.9%Q2 2013
RAREUltragenyx Pharmaceutical Inc.$11.1M2.06%0.38%+658.0%Q2 2025
AGIOAgios Pharmaceuticals, Inc.$10.7M1.97%0.46%-1.2%Q1 2025
SNDXSyndax Pharmaceuticals Inc$10.1M1.86%0.75%+47.4%Q1 2020
EHTHeHealth, Inc.$6.66M1.23%5.05%-2.1%Q3 2020
DNLIDenali Therapeutics Inc.$5.92M1.10%0.28%+70.1%Q2 2025
ALGNAlign Technology Inc$5.73M1.06%0.06%+21.1%Q1 2014
ALKSAlkermes plc.$5.52M1.02%0.11%-16.8%Q4 2020
RNAMAvidity Biosciences, Inc.$4.79M0.89%0.07%-7.6%Q2 2025
MIRMMirum Pharmaceuticals, Inc.$4.74M0.88%0.13%Not reportedQ4 2021
CDNACareDx, Inc.$4.6M0.85%0.62%NewQ3 2025
TSHATaysha Gene Therapies, Inc.$4.07M0.75%0.45%Not reportedQ4 2023
NUVBNuvation Bio Inc.$3.78M0.70%0.30%+32.1%Q1 2024
ACRSAclaris Therapeutics, Inc.$2.98M0.55%1.45%+12.7%Q1 2024
CRSPCRISPR Therapeutics AG$2.67M0.49%0.04%-7.6%Q2 2025
TVTXTravere Therapeutics, Inc.$2.65M0.49%0.12%Not reportedQ4 2020
EWEdwards Lifesciences Corp$2.62M0.48%0.01%-14.8%Q3 2024
NBIXNeurocrine Biosciences Inc$2.54M0.47%0.02%+35.9%Q1 2025
STOKStoke Therapeutics, Inc.$2.48M0.46%0.19%-16.2%Q1 2024
PYXSPyxis Oncology, Inc.$2.3M0.43%1.67%Not reportedQ3 2024
BNTXBioNTech SE$1.93M0.36%0.01%-22.2%Q3 2024
BCYCBicycle Therapeutics PLC$1.71M0.32%0.32%-11.2%Q3 2024
ALDXAldeyra Therapeutics, Inc.$1.18M0.22%0.37%Not reportedQ2 2019
HUMHumana Inc$1.04M0.19%0.00%Not reportedQ1 2024
ORKAOruka Therapeutics, Inc.$791K0.15%0.12%NewQ3 2025
ABEOAbeona Therapeutics Inc.$575K0.11%0.21%Not reportedQ3 2024
URGNUroGen Pharma Ltd.$489K0.09%0.05%Not reportedQ1 2020
PRQRProQR Therapeutics N.V.$402K0.07%0.18%NewQ3 2025
AKTXAkari Therapeutics Plc$147K0.03%0.00%Not reportedQ4 2024
GBIOGeneration Bio Co.$92.1K0.02%0.22%-90.0%Q2 2024
Premium opens every quarter this fund has filed

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.